BSN CAPITAL PARTNERS 13F: Exits HCA Healthcare (HCA) Stake

Bsn Capital Partners sold out of its entire holding in Hca Healthcare, Inc. (NYSE:HCA), offloading all 52,786 shares during the period. The complete exit appeared in a Form 13F filing with the Securities and Exchange Commission on October 23, 2026. The stock closed at $469.03 on the day of the filing.

HCA HCA Healthcare, Inc.

$469.03 ▲ +0.24% year to date

1M 3M YTD

Daily close · Oct 23, 2026

What Changed in Bsn Capital Partners's Hca Position

Bsn Capital Partners completely closed out its investment in the healthcare provider, dropping its prior count of 52,786 shares down to zero. Because the firm sold its entire stake, the move represents a 100% reduction in its holdings for the stock.

Other Institutional Activity in Hca Healthcare, Inc.

Other major institutional investors adjusted their positions in the medical facility operator during recent quarters. Mutual of America Capital Management cut its holdings by 6,150 shares, ending with 15,017 shares valued at about $6,408,355 after a 29.1% reduction. Brandes Investment Partners lowered its stake by 43,607 shares, leaving it with 343,224 shares worth roughly $134,025,536.41 following an 11.3% decrease. Royal London Asset Management trimmed its position by 151,456 shares down to 577,119 shares valued at about $225,359,192.67, a 20.8% cut. Sanders Capital, LLC reduced its holdings by 128,985 shares, resulting in a stake of 8,828,287 shares worth $4,140,731,440 after a 1.4% drop. Conversely, First Eagle Investment Management, LLC grew its holdings by 41,007 shares, finishing with 3,295,565 shares worth about $1,545,718,847 after a 1.3% increase.

HCA Healthcare, Inc. Stock Up 2.1%

Hca Healthcare, Inc. shares recently traded at $469.03 as of October 24, 2026, remaining right around the $469.03 close recorded when the filing dropped. The stock trades above its 50-day moving average of $430.37 and sits higher than its 200-day moving average of $444.67. Over the past year, the shares have moved between a low of $353.99 and a high of $556.52.

Recent Earnings

Hca Healthcare, Inc. reported strong financial results recently, with trailing twelve month revenue totaling $78,012,997,632 and earnings of $29.83 per share. The company is scheduled to release its next financial results on October 27, 2026.

Dividend

The healthcare company currently pays an annual dividend rate of $3.12 per share, which translates to a dividend yield of 0.67%. The payout ratio stands at 10.1% of earnings.

Insider Buying and Selling at HCA Healthcare, Inc.

Company insiders executed several sales earlier in the year prior to the filing. Chief Executive Officer Samuel N Hazen sold 42,877 shares on February 3, 2026, for a total value of $21,483,275. Officer Jennifer Berres disposed of 8,020 shares on February 11, 2026, valued at $4,126,950. Officer Christopher F Wyatt sold 4,000 shares at $505.00 each on February 11, 2026, totaling $2,020,000. Finally, Officer Michael R. Mcalevey offloaded 1,694 shares at $533.37 per share on February 18, 2026, worth $903,537.

Analysts Set New Price Targets

Wall Street firms updated their views on the stock across September and October. RBC Capital reiterated its outperform rating and set a target of $435.00 on September 8, 2026, before raising its target to $496.00 on October 7, 2026. Leerink Partners maintained an outperform rating with a $492.00 target on September 18, 2026. BMO Capital initiated coverage with an outperform rating and a $495.00 target on September 23, 2026. TD Cowen maintained a buy rating while lifting its target from $431.00 to $460.00 on October 12, 2026. Overall, the stock carries a consensus buy recommendation from 22 analysts, with a mean price target of $460.59.

About Hca Healthcare, Inc.

Hca Healthcare, Inc. operates medical care facilities and provides health care services across the United States. Headquartered in Nashville, Tennessee, the company manages hospitals and surgery centers that serve communities nationwide.

Bottom Line

Institutional investors continue to adjust their holdings in Hca Healthcare, Inc. as the company prepares to report its upcoming earnings on October 27, 2026. Market watchers will closely monitor these results to see if the firm's financial performance matches the consensus buy outlook from Wall Street analysts.